biotech
biotech Articles
CRISPR Therapeutics shares made a handy gain on Thursday after the company announced a key FDA decision concerning its collaboration with Vertex Pharmaceuticals.
Published:
Last Updated:
Ionis Pharmaceuticals shares were relatively flat on Wednesday after the company announced a new collaboration with Roche to develop IONIS-FB-LRx for the treatment of complement-mediated diseases.
Published:
Last Updated:
The September 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Published:
Last Updated:
Mylan shares hit a 52-week low after Mapi Pharma announced midstage results from its multiple sclerosis trial.
Published:
Last Updated:
Affimed shares took a big step back early on Tuesday after the company announced that it has placed its AFM11 on clinical hold, and has notified the global health authorities of its decision.
Published:
Last Updated:
Biopharmaceutical company Orchard RX Limited has filed with the SEC for its initial public offering.
Published:
Last Updated:
Akcea Therapeutics shares pulled back on Monday after the company announced a big change to its board of directors.
Published:
Last Updated:
Exelixis shares dipped on Monday after the company announced that it has initiated a late-stage trial in patients with radioiodine-refractory differentiated thyroid cancer (DTC).
Published:
Last Updated:
Here 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the remainder of October.
Published:
Last Updated:
Vaxart shares more than doubled on Thursday after the company announced positive results from the midstage trial of its influenza oral tablet vaccine.
Published:
Last Updated:
Arrowhead Pharmaceuticals shares stumbled on Thursday after it announced a license and collaboration agreement with Janssen Pharmaceutica, a subsidiary of Johnson & Johnson.
Published:
Last Updated:
Synthetic biology company Twist Bioscience has filed with the SEC regarding its initial public offering.
Published:
Last Updated:
Clovis Oncology shares jumped on Tuesday after the U.S. Food and Drug Administration (FDA) gave a critical update.
Published:
Last Updated:
Akorn shares were crushed early on Monday after a Delaware judge ruled that German health care group Fresenius could walk away from its $4.75 billion merger deal.
Published:
Last Updated:
Here is a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of October.
Published:
Last Updated: